The complexity of clinical trial designs and data streams are increasing with a greater percentage of data coming from non-EDC sources such as specialty labs, genomics, and wearables. As the volume of research data, systems, and sources grow, it is critical for life sciences companies to have a well defined clinical data strategy that maximizes the value of every data point. This whitepaper describes the fundamental steps and key considerations you need to help your organization transform into a more digitally enabled enterprise. This whitepaper will answer: